- Home
- ATNF vs AVGR Comparison
ATNF vs AVGR Comparison
Compare ATNF & AVGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNF
- AVGR
- Stock Information
- Founded
- ATNF 2016
- AVGR 2007
- Country
- ATNF United States
- AVGR United States
- Employees
- ATNF N/A
- AVGR N/A
- Industry
- ATNF Biotechnology: Pharmaceutical Preparations
- AVGR Medical/Dental Instruments
- Sector
- ATNF Health Care
- AVGR Health Care
- Exchange
- ATNF Nasdaq
- AVGR Nasdaq
- Market Cap
- ATNF 1.8M
- AVGR 2.1M
- IPO Year
- ATNF N/A
- AVGR 2015
- Fundamental
- Price
- ATNF $1.42
- AVGR $1.01
- Analyst Decision
- ATNF
- AVGR Strong Buy
- Analyst Count
- ATNF 0
- AVGR 1
- Target Price
- ATNF N/A
- AVGR $5.00
- AVG Volume (30 Days)
- ATNF 46.0K
- AVGR 581.1K
- Earning Date
- ATNF 11-07-2024
- AVGR 10-24-2024
- Dividend Yield
- ATNF N/A
- AVGR N/A
- EPS Growth
- ATNF N/A
- AVGR N/A
- EPS
- ATNF N/A
- AVGR N/A
- Revenue
- ATNF N/A
- AVGR $7,429,000.00
- Revenue This Year
- ATNF N/A
- AVGR N/A
- Revenue Next Year
- ATNF $54.15
- AVGR $93.49
- P/E Ratio
- ATNF N/A
- AVGR N/A
- Revenue Growth
- ATNF N/A
- AVGR N/A
- 52 Week Low
- ATNF $1.31
- AVGR $0.90
- 52 Week High
- ATNF $12.03
- AVGR $6.55
- Technical
- Relative Strength Index (RSI)
- ATNF 35.64
- AVGR 46.48
- Support Level
- ATNF $1.38
- AVGR $0.93
- Resistance Level
- ATNF $1.58
- AVGR $1.34
- Average True Range (ATR)
- ATNF 0.16
- AVGR 0.12
- MACD
- ATNF -0.05
- AVGR 0.02
- Stochastic Oscillator
- ATNF 4.60
- AVGR 16.00
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
About AVGR Avinger Inc.
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.